Walder Wyss advised Anklin, a Swiss distributor medical instruments and devices, in transaction that brought the company to become part of German Karl Storz. The parties Reinach-based Anklin is active in the distribution a distributor
Tags :Robert von Rosen
Axalta Coating Systems Group has completed the acquisition of André Koch, a well-established provider of car repair and maintenance services. André Koch, previously privately owned, has excelled in the premium segment of the refinish market
In a groundbreaking move, Boehringer Ingelheim has sealed the deal to acquire T3 Pharmaceuticals, a dynamic Swiss biotech company, for a staggering amount of up to 450 million CHF. This strategic move signals a major leap
Coopers Group, a Swiss personnel service provider in the field of professional and executive search, has successfully acquired Zurich-based iET Group, which draws on many years of expertise in recruitment processes. This strategic acquisition is
GEODIS, one of the world’s leading transport and logistics companies, has acquired International Transport & Shipping. ITS is an independent Swiss freight forwarder founded in 1992 and headquartered in Reinach in the canton of Basel-Landschaft.
PwC Switzerland, the well-known audit and advisory firm in Switzerland, has acquired Avoras Holding as part of its growth strategy in the consulting area. The Swiss firm specialising in SAP business transformation consultancy in the
The Zurich-based Skribble, a specialist for electronic signatures, has completed a round of funding with an investment volume of EUR 10 million. The round is led by Acton Capital Partners from Munich, an international venture capital
The groupe. id has been acquired by German private equity firm Elvaston Capital Management. Based in La Chaux-de-Fonds and also present in Yverdon-les-Bains, the groupe.id is a renowed Swiss provider of enterprise resource planning
Elvaston, an entrepreneur-led private equity firm, has sold its participation in Magnolia International to GENUI. The investment company has acquired a majority stake in Magnolia and will injects significant growth capital into the company. Magnolia
The Swiss pharmaceutical BioVersys has raised CHF 24.2 million in a first closing of its Series C round. This first closing was significantly oversubscribed by both existing and new investors from diverse geographies. The company intends